1. Kim, H.S., Hariri, K., Zhang, X.N., Chen, L.C., Katz, B.B., Pei, H., Louie, S.G. and Zhang, Y. Synthesis of Site-Specific Fab-Drug Conjugates Using ADP-Ribosyl Cyclases. Protein Sci., 2024, 33, e4924. PMID: 38501590
  2. Yu, P.W., Kao, G., Dai, Z., Nasertorabi, F. and Zhang, Y. Rational Design of Humanized Antibody Inhibitors for Cathepsin S. Arch. Biochem. Biophys. 2024, 751, 109849. PMID: 38061628
  3. Kim, H.S. and Zhang, Y. Generation of Bispecific Antibodies by Functionalized Poly-ADP-Ribose Polymers. Curr. Protoc. 2023, 3, e958. PMID: 38147359
  4. Stephens, E.N., Zhang, X.N., Lam, A.T., Li, J., Pei, H., Louie, S.G., Wang, C.C.C. and Zhang, Y. A Ribose-Functionalized NAD+ with Versatile Activity for ADP-Ribosylation. Chem. Commun. 2023, 59, 13843-13846. PMID: 37921487
  5. Cheng, Q., Zhang, X.N., Li, J., Chen, J., Wang, Y. and Zhang, Y. Synthesis of Bispecific Antibody Conjugates Using Functionalized Poly-ADP-Ribose Polymers. Biochemistry, 2023, 62, 1138–1144. PMID: 36821831
  6. Cheng, Q., Zhang, X.N., Zhang, L., Chen, J., Wang, Y. and Zhang, Y. A Poly-ADP-Ribose Polymer-GCSF Conjugate. Biomacromolecules 2022, 23, 5267-5272. PMID: 36350184
  7. Cheng, Q., Dai, Z., Smbatyan, G., Epstein, A.L., Lenz, H.J. and Zhang, Y. Eliciting Anti-Cancer Immunity by Genetically Engineered Multifunctional Exosomes. Mol. Ther. 2022, 30, 3066-3077. PMID: 35746867
  8. Zhang, X.N., Lam, A.T., Cheng, Q., Courouble, V.V., Strutzenberg, T.S., Li, J., Wang, Y., Pei, H., Stiles, B.L., Louie, S.G., Griffin, P.R. and Zhang, Y. Discovery of an NAD + Analogue with Enhanced Specificity for PARP1. Chem. Sci., 2022, 13, 1982-1991. PMID: 35308855
  9. Cheng Q, Dai Z, Shi X, Duan X, Wang Y, Hou T, and Zhang Y. Expanding the Toolbox of Exosome-Based Modulators of Cell Functions. Biomaterials 2021, 277, 121129. PMID: 34534861
  10. Li, J., Stephens, E. and Zhang, Y. Extracellular Vesicles in Tumor Immunotherapy. In Systemic Drug Delivery Strategies: Volume 2 of Delivery Strategies and Engineering Technologies in Cancer Immunotherapy. Elsevier Science, 2021, 231-256. Link
  11. Dai, Z., Zhang, X.N., Cheng, Q., Fei, F., Hou, T., Li, J., Abdolvahabi, A., Watanabe, J., Pei, H., Smbatyan, G., Xie, J., Lenz, H.J., Louie, S.G. and Zhang, Y. Site-Specific Antibody-Drug Conjugates with Variable Drug-to-Antibody-Ratios for AML Therapy. J. Control. Release 2021, 336, 433-442. PMID: 34197861
  12. Lambeth, T.R., Dai, Z., Zhang, Y. and Julian, R.R. A Two-Trick Pony: Lysosomal Protease Cathepsin B Possesses Surprising Ligase Activity. RSC Chem. Biol. 2021, 2, 606-611. PMID: 34291207
  13. Lam, A.T., Zhang, X.N., Courouble, V.V., Strutzenberg, T.S., Pei, H., Stiles, B.L., Louie, S.G., Griffin, P.R. and Zhang, Y. A Bifunctional NAD+ for Profiling Poly-ADP-Ribosylation-Dependent Interacting Proteins. ACS Chem. Biol. 2021, 16, 389-396. PMID: 33524253
  14. Shi, X., Zhang, X.N., Chen, J., Cheng, Q., Pei, H., Louie, S.G. and Zhang, Y. A Poly-ADP-Ribose Polymer-Based Antibody-Drug Conjugate. Chem. Sci. 2020, 11, 9303-9308. PMID: 33623656
  15. Shi, X. and Zhang, Y. A Humanized Antibody Inhibitor for Cathepsin L. Protein Sci. 2020, 29, 1924-1930. PMID: 32683733
  16. Dai, Z., Zhang, X.N., Nasertorabi, F., Cheng, Q., Li, J., Katz, B.B., Smbatyan, G., Pei, H., Louie, S. G., Lenz, H.J., Stevens, R.C. and Zhang, Y. Synthesis of Site-Specific Antibody-Drug Conjugates by ADP-Ribosyl Cyclases. Sci. Adv. 2020, 6, eaba6752. PMID: 32537509
  17. Madern, J.M., Kim, R.Q., Misra, M., Dikic, I., Zhang, Y., Ovaa, H., Codee, J.D.C., Filippov, D.V. and van der Heden van Noort, G.J. Synthesis of Stable NAD+ Mimics as Inhibitors for the Legionella Pneumophila Phosphoribosyl Ubiquitinating Enzyme SdeC. ChemBioChem 2020, 21, 2903-2907. PMID: 32421893
  18. Park, M., Vaikari, V.P., Lam, A.T., Zhang, Y., Mackay, J.A. and Alachkar, H. Anti-FLT3 nanoparticles for acute myeloid leukemia: preclinical pharmacology and pharmacokinetics. J. Control. Release 2020, 324, 317-329. PMID: 32428520
  19. Dai, Z., Cheng, Q. and Zhang, Y. Rational Design of a Humanized Antibody Inhibitor of Cathepsin B. Biochemistry 2020, 59, 1420-1427. PMID:32212642
  20. Cheng, Q., Shi, X. and Zhang, Y. Reprogramming Exosomes for Immunotherapy. Methods Mol. Biol. 2020, 2097, 197–209. PMID:31776927
  21. Shi, X., Cheng, Q., Hou, T., Han, M., Smbatyan, G., Lang, J.E., Epstein, A.L., Lenz, H.J. and Zhang, Y. Genetically Engineered Cell-Derived Nanoparticles for Targeted Breast Cancer Immunotherapy. Mol. Ther. 2020, 28, 536–547. PMID:31843452
  22. Shi, X., Cheng, Q. and Zhang, Y. Reprogramming Extracellular Vesicles with Engineered Proteins. Methods 2020, 177, 95-102. PMID:31568822
  23. Zhang, X.N., Cheng, Q., Chen, J., Lam, A.T., Lu, Y., Dai, Z., Pei, H., Evdokimov, N.M., Louie, S.G. and Zhang, Y. A Ribose-Functionalized NAD+ with Unexpected High Activity and Selectivity for Protein Poly-ADP-Ribosylation. Nat. Commun. 2019, 10, 4196. PMID:31519936
  24. Zhang XN, Dai Z, Cheng Q and Zhang Y. Chemoenzymatic Preparation of 4′-Thioribose NAD. Curr. Protoc. Nucleic Acid Chem. 2019 PMID:30951610
  25. Cheng, Q., Shi, X., Han, M., Smbatyan, G., Lenz, H.J. and Zhang, Y. Reprogramming Exosomes as Nanoscale Controllers of Cellular Immunity. J. Am. Chem. Soc. 2018, 140, 16413–16417 PMID30452238
  26. Dai, Z., Zhang, X.N., Nasertorabi, F., Cheng, Q., Pei, H., Louie, S.G., Stevens, R.C. and Zhang, Y. Facile Chemoenzymatic Synthesis of a Novel Stable Mimic of NAD+. Chem. Sci. 2018,  9, 8337-8342 Featured in Front Cover PMC6256357
  27. Chen, J., Lam, A.T. and Zhang, Y. A Macrodomain-Linked Immunosorbent Assay (MLISA) for Mono-ADP-Ribosyltransferases. Anal Biochem., 2017, 543, 132-139. PMID29247608
  28. Du, J., Cao Y., Liu, Y., Wang, Y., Zhang, Y., Fu, G., Zhang, Y., Lu, L., Luo, X., Kim, C.H., Schultz, P.G. and Wang, F. Engineering Bifunctional Antibodies with Constant Region Fusion Architectures. J. Am. Chem. Soc., 2017, 139, 18607–18615. PMID29186655
  29. Liu, Y., Wang, Y., Zhang, Y., Liu, T., Jia, H., Zou, H., Fu, Q., Zhang, Y., Lu, L., Chao, E., Parker, H., Nguyen-Tran, V.T.B., Shen, W., Wang, D., Schultz, P.G. and Wang, F. Rational Design of Dual Agonist-Antibody Fusions as Long-Acting Therapeutic Hormones. ACS Chem. Biol., 2016, 11, 2991-2995. PMC5148668
  30. Luo, X., Wang, T.S.A., Zhang, Y., Wang, F. and Schultz, P.G. Stabilizing Protein Motifs with a Genetically Encoded Metal-Ion Chelator. Cell Chem. Biol., 2016, 23,1098-102. PMID27662253
  31. Wang, R.E., Wang, Y., Zhang, Y., Gabrelow, C., Zhang, Y., Chi, V., Fu, Q., Luo, X., Wang, D., Joseph, S., Johnson, K., Chatterjee, A.K., Wright, T.M., Nguyen-Tran, V.T.B., Teijaro, J., Theofilopoulos, A.N., Schultz, P.G. and Wang, F. Rational Design of a Kv1.3 Channel-Blocking Antibody as a Selective Immunosuppressant. Proc. Natl. Acad. Sci. U.S.A., 2016, 113, 11501-11506. PMC5068325
  32. Zhang, Y., Zou, H., Wang, Y., Caballero, D., Gonzalez, J., Chao, E., Welzel, G., Shen, W., Wang, D., Schultz, P.G. and Wang, F. Rational Design of a Humanized Glucagon-Like Peptide-1 Receptor Agonist Antibody. Angew. Chem. Int. Ed. Engl., 2015, 54, 2126-30.
    PMID25556336
  33. Liu, T., Zhang, Y. (co-first author), Liu, Y., Wang, Y., Jia, H., Kang, M., Luo, X., Caballero, D., Gonzalez, J., Wang, D., Woods, A., Schultz, P.G. and Wang, F. Functional Human Antibody CDR Fusions as Long-Acting Therapeutic Endocrine Agonists. Proc. Natl. Acad. Sci. U.S.A., 2015,112,1356-61. PMC4321239
  34. Zhang, Y. (co-first author), Liu, Y., Wang, Y., Schultz, P.G. and Wang, F. Rational Design of Humanized Dual-Agonist Antibodies. J. Am. Chem. Soc., 2015, 137, 38-41.
    PMID25494484
  35. Lu, H., Zhou, Q., Deshmukh, V., Phull, H., Ma, J., Tardif, V., Naik, R.R., Bouvard, C., Zhang, Y., Choi, S., Lawson, B.R., Zhu, S., Kim, C.H. and Schultz, P.G. Targeting Human C-Type Lectin-like Molecule-1 (CLL1) with a Bispecific Antibody for Immunotherapy of Acute Myeloid Leukemia. Angew. Chem. Int. Ed. Engl., 2014, 53, 9841–9845. PMC4280064
  36. Zhang, Y., Goswami, D., Wang, D., Wang, T.S.A., Sen, S., Magliery, T.J., Griffin, P.R., Wang, F. and Schultz, P.G. An Antibody with a Variable Region Coiled-Coil “Knob” Domain. Angew. Chem. Int. Ed. Engl., 2014, 53, 132-135. PMC3926434
  37. Zhang, Y., Evans, G.B., Clinch, K., Crump, D.R., Harris, L.D., Fröhlich, R.F.G., Tyler, P.C., Hazleton, K.Z., Cassera, M.B. and Schramm, V.L. Transition State Analogues of Plasmodium falciparum and Human Orotate Phosphoribosyltransferases. J. Biol. Chem., 2013, 288, 34746-54. PMC3843086
  38. Zhang, Y., Wang, D., Welzel, G., Wang, Y., Schultz, P.G. and Wang, F. An Antibody CDR3-Erythropoietin Fusion Protein. ACS Chem. Biol., 2013, 8, 2117-2121. PMC3800483
  39. Zhang, Y., Wang, D., de Lichtervelde, L., Sun, S.B., Smider, V.V., Schultz, P.G. and Wang, F. Functional Antibody CDR3 Fusion Proteins with Enhanced Pharmacological Properties. Angew. Chem. Int. Ed. Engl., 2013, 52, 8295-8298. PMC3783209
  40. Wang, F., Sambandan, D., Wang, J., Halder, R., Batt, S., Weinrick, B.C., Ahmad, I., Yang, P, Zhang, Y., Kim, J., Hassani, M., Huszar, S., Mikusova, K., Chatterjee, A., Besra, G., Futterer, K., Jacobs, W.R. Jr. and Schultz, P.G. Identification of a Small Molecule with Activity against Drug-resistant and Persistent Tuberculosis. Proc. Natl. Acad. Sci. U.S.A., 2013, 110, E2510-7. PMC3703973
  41. Wang, F., Ekiert, D.C., Ahmad, I., Li, W., Zhang, Y., Bazirgan, O., Torkamani, A., Raudsepp, T., Mwangi, W., Criscitiello, M.F., Wilson, I.A., Schultz, P.G. and Smider. V.V. Reshaping Antibody Diversity. Cell, 2013, 153, 1379-93. PMC4007204
  42. Cassera, M.B., Zhang, Y. (co-first author), Hazleton, K.Z. and Schramm, V.L. Purine and Pyrimidine Pathways as Targets in Plasmodium falciparum. Curr. Top. Med. Chem., 2011, 11, 2103-2115. PMC3319363
  43. Zhang, Y. and Schramm, V.L. Ground-State Destabilization in Orotate Phosphoribosyltransferases by Binding Isotope Effects. Biochemistry, 2011, 50, 4813-4818. PMC3101270
  44. Vetting, M.W., Hegde, S.S., Zhang, Y. and Blanchard, J.S. Pentapeptide Repeat Proteins that Act as Topisomerase Poison Resistance Factors Have a Common Dimer Interface. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun., 2011, 67, 296-302. PMC3053150
  45. Zhang, Y., Deng, H. and Schramm, V.L. Leaving Group Activation and Pyrophosphate Ionic State at the Catalytic Site of Plasmodium falciparum Orotate Phosphoribosyltransferase. J. Am. Chem. Soc., 2010, 132, 17023-17031. PMC3012390
  46. Zhang, Y. and Schramm, V.L. Pyrophosphate Interactions at the Transition States of Plasmodium falciparum and Human Orotate Phosphoribosyltransferases. J. Am. Chem. Soc., 2010, 132, 8787-8794. PMC2892240
  47. Abdo, M., Zhang, Y., Schramm, V.L. and Knapp, S. Electrophilic Aromatic Selenylation: New OPRT Inhibitors. Org. Lett., 2010, 12, 2982-2985. PMC2906230
  48. Zhang, Y., Luo, M. and Schramm, V.L. Transition States of Plasmodium falciparum and Human Orotate Phosphoribosyltransferases. J. Am. Chem. Soc., 2009, 131, 4685-4694. PMC2669657
  49. Zhang, Y. (co-first author), Liu, S., Lajoie G. and Merrill, A.R. The Role of the Diphthamide-containing Loop within Eukaryotic Elongation Factor 2 in ADP-Ribosylation by Pseudomonas aeruginosa Exotoxin A.  Biochem. J., 2008, 413, 163-174. PMID18373493